Compare Abeona Therapeutics Inc (ABEO) vs Archer Aviation Inc (ACHR) Price & Performance

Abeona Therapeutics IncTrade

Archer Aviation IncTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs Archer Aviation Inc — how do they compare? Abeona Therapeutics Inc trades at $7.42 (market cap $421.19M), while Archer Aviation Inc trades at $6.44 (market cap $5.23B). The key difference: Archer Aviation Inc is far larger — about 12.4× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Archer Aviation Inc nearer its low. Which is the better fit depends on your goals.

	ABEO	ACHR
Market Cap	$421.19M	$5.23B
Sector	Health	Industrials
52-Week High	$7.45	$13.64
52-Week Low	$4.17	$4.44
Enterprise Value	$276.10M	$3.79B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Abeona Therapeutics Inc

No Aura AI signal available yet.

Archer Aviation Inc

Archer Aviation (ACHR) trades at $6.41, up 2.4% today, with a bullish technical signal from moving averages. The stock shows strong analyst support (78% buy ratings) amid recent news of a strategic Boeing deal to acquire three businesses, boosting its defense and AI aviation portfolio. However, fundamentals remain weak with a P/S ratio of 719.85 and deeply negative profit margins, as the company is pre-revenue and burning cash to develop its eVTOL technology.

Outlook hinges on successful commercialization of air taxis and integration of Boeing assets, offering growth potential but carrying high execution risk. Investors face substantial losses until revenue scales, with net income margin at -11,590% in 2026. The Boeing partnership provides a cash flow bridge via defense revenue, yet dilution from equity offerings and regulatory delays pose near-term headwinds.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABEO

View details →

ACHR

Archer Aviation nears commercialization with strong growth and undervalued stock despite recent gainsSeeking Alpha · 22 hours agoBullish Archer Aviation stock jumps 11% on Boeing deal details and strong Q2 revenue growth24/7 Wall Street · 1 day agoBullish Red Cat shares jump 6.84% post-earnings despite revenue miss, driven by strong growth and sector momentum.24/7 Wall Street · 1 day agoBullish View details →

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

About Archer Aviation Inc

Archer Aviation develops electric vertical takeoff and landing (eVTOL) aircraft for urban air mobility. Its flagship, Midnight aircraft, is designed for air taxi services, aiming to transform urban travel with sustainable aviation.